Skip to main content
Figure 5 | Infectious Agents and Cancer

Figure 5

From: Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer

Figure 5

Specimens of BC. A = urothelial carcinoma with faint but detectable membranous and cytoplasmic positivity in tumor cells for FGFR3 from non-HCV infected patients, B = BC with moderate cytoplasmic positivity in most tumor cells for FGFR3 from HCV infected patients and C = BC with strong cytoplasmic positivity in tumor cells for FGFR3 from HCV infected patients (Immunoperoxidase DAB X400).

Back to article page